Quest Diagnostics: COVID-19 Testing Not Enough To Overcome Negative Effects [Seeking Alpha]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Seeking Alpha
Quest Diagnostics: COVID-19 Testing Not Enough To Overcome Negative EffectsApr. 17, 2020 12:47 PM ET|About:Quest Diagnostics Incorporated (DGX)Includes:LHby: M. Wayne ToepkeValue, long-term horizonDoctor of ValueSummaryQuest Diagnostics recently announced a series of cost-saving actions to try and shore up the company's financial situation ahead of the coming recession.A discounted free cash flow analysis indicates that shares are pricing in a fairly bearish scenario for the company.Value investors may find the shares attractive, but those looking for fast growth will likely want to look elsewhere.The CEO of Quest Diagnostics (NYSE:COVID-19 Revenue ImpactQuest has beentestingOTCQX:RHHBYHOLXcarried outAssuming Quest performs 45,000 tests per day throughout the year at $51.31, that would equate to $845MM. Despite the impressive revenue potential, it has not been enough to offset the40% declineobservedCOVID-19 Impact on EarningsOnly 12 of Quest's locations are capable of carrying out COV
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States [Yahoo! Finance]Yahoo! Finance
- Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United StatesBusiness Wire
- Function Health's $2.5 Billion Bet And Are Blood Testing Startups Sustainable [Forbes]Forbes
- Quest Diagnostics (DGX): A Fresh Look at Valuation After Strong Q3 Earnings and Raised Outlook [Yahoo! Finance]Yahoo! Finance
- How the Narrative Around Quest Diagnostics Is Evolving After Recent Results and Analyst Updates [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 10/21/25 - Beat
DGX
Sec Filings
- 11/28/25 - Form 4
- 11/28/25 - Form 4
- 11/25/25 - Form 144
- DGX's page on the SEC website